ClinVar Miner

Submissions for variant NM_144612.6(LOXHD1):c.6353G>A (p.Gly2118Glu) (rs763915229)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000613067 SCV000731809 uncertain significance not specified 2017-08-03 criteria provided, single submitter clinical testing The p.Gly2118Glu variant in LOXHD1 has been reported in the compound heterozygou s state in 1 individual with hearing loss (Zazo Seco 2017). It has been identifi ed in 4/58252 European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://; dbSNP rs763915229). Although this variant has been seen in the general population, its frequency is not high enough to rule ou t a pathogenic role. Computational prediction tools and conservation analyses su ggest that this variant may impact the protein, though this information is not p redictive enough to determine pathogenicity. In summary, the clinical significan ce of the p.Gly2118Glu variant is uncertain.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.